Purple Biotech Ltd.
NASDAQ: PPBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gil Efron
- Employees
- 9
- Headquarters
- Rehovot, Israel
- IPO year
- 2015
- Market cap
- $241.6K
- Website
- https://purple-biotech.com
Loading PPBT…
Loading profile data…Frequently asked questions about PPBT
What does Purple Biotech Ltd. (PPBT) do?
Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic...
Where does PPBT trade?
Purple Biotech Ltd. (PPBT) trades on the NASDAQ Capital Market.
What sector is PPBT in?
Purple Biotech Ltd. (PPBT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Purple Biotech Ltd.?
Gil Efron is the chief executive officer of Purple Biotech Ltd. (PPBT).
Where is Purple Biotech Ltd. headquartered?
Purple Biotech Ltd. is headquartered in Israel.
Does PPBT pay a dividend?
Purple Biotech Ltd. (PPBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PPBT go public?
Purple Biotech Ltd. (PPBT) completed its initial public offering in 2015.
Is PPBT an ADR?
Yes — PPBT is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Purple Biotech Ltd. reporting and dividends follow the underlying issuer.